BRI3BP anticorps

N° du produit ABIN7254535

Détail du produit anti-BRI3BP anticorps

Antigène: BRI3BP (BRI3 Binding Protein (BRI3BP))

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BRI3BP est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Attributs du produit: Polyclonal Antibody

Purification: Antigen affinity purification

Immunogène: Synthetic peptide of human BRI3BP

Isotype: IgG

Information d'application

Indications d'application: WB 1:500-1:2000, IHC 1:30-1:150, ELISA 1:5000-1:10000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.9 mg/mL

Buffer: PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur BRI3BP

Antigène: BRI3BP (BRI3 Binding Protein (BRI3BP))

Autre désignation: BRI3BP (BRI3BP Produits)

Synonymes: anticorps fa20c12, anticorps wu:fa20c12, anticorps kg19, anticorps bnas1, anticorps hccr-2, anticorps BNAS1, anticorps HCCR-1, anticorps HCCR-2, anticorps HCCRBP-1, anticorps KG19, anticorps 2410150I18Rik, anticorps AI841257, anticorps AW742481, anticorps bri3 binding protein, anticorps BRI3 binding protein pseudogene, anticorps BRI3 binding protein L homeolog, anticorps BRI3 binding protein, anticorps Bri3 binding protein, anticorps bri3bp, anticorps LOC452360, anticorps bri3bp.L, anticorps BRI3BP, anticorps Bri3bp

Sujet: BRI3BP (BRI3 binding protein), also known as BNAS1, HCCR-1, I3-binding protein or cervical cancer 1 proto-oncogene-binding protein KG19, is a 251 amino acid multi-pass membrane protein. Though widely expressed, BRI3BP is found at highest levels in brain, kidney and liver where it localizes to the endoplasmic reticulum (ER) and is involved in ER structural dynamics and mitochondrial viability. Possessing pro-apoptotic properties and the ability to potentiate drug-induced apoptosis, BRI3BP overexpression has been shown to enhance caspase-3 and mitochondrial cytochrome c release in etoposide-treated human embryonic kidney 293T cells.

Poids moléculaire:

Observed_MW: Refer to figures

Calculated_MW: 28 kDa

UniProt: Q8WY22